🇺🇸 FDA
Company

Olema

Olema Pharmaceuticals

OLMA pharma USA

Quick answer

Olema is a pharma company (OLMA) headquartered in SAN FRANCISCO, CA, USA with 4 tracked pipeline programs.

Pipeline (4)

project

Palazestrant

Breast Cancer

Phase 3 · small_molecule · active

3 trials project

OP-1250

Hormone Receptor Positive Breast Carcinoma

Phase 2 · small_molecule · completed

1 trials project

OP-3136

Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)

Phase 1 · small_molecule · active

1 trials project

Palazestrant

Metastatic Breast Cancer

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12428379

Acylsulfonamide KAT6A inhibitors

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12370181

Regimens of estrogen receptor antagonists

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11672785

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11229630

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10624878

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10292971

Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs

Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9018244

Benzopyran compounds, compositions and uses thereof

Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8071545

Therapies and compositions for controlling the stress mechanism and for stabiliz

Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)